Florida Eye Clinic
Altamonte Springs, Florida 32701
2 studies enrolling now · 13 studies all time
What they study most
Age-Related Maculopathy, Diabetic Macular Edema, Diabetic Retinopathy, Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration, Macular Edema, Macular Edema Secondary to Inflammation, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion, Vitreous Hemorrhage
Studies at this site
- A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy — Recruiting now
- A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE — Recruiting now
- A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK — Recruiting now
- A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
- ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD) — Completed
- Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB) — Status unconfirmed
- A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) — Completed
- Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) — Completed
- Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III) — Running, not enrolling
- A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration — Completed
- Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema — Completed
- Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration — Stopped early
- Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage — Completed